Viatris
Search results
The Upjohn Company was an American pharmaceutical manufacturing firm founded in 1886 in Hastings, Michigan, by Dr. William E. Upjohn who was an 1875 graduate of the University of Michigan medical school.
Nov 16, 2020 · NEW YORK-- (BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) announced today that it has completed the transaction to spin off its Upjohn Business and combine it with Mylan N.V. to form Viatris Inc.
Jul 29, 2019 · HERTFORDSHIRE, England & PITTSBURGH & Mylan N.V. (Nasdaq: MYL) and Pfizer Inc. (NYSE: PFE) today announced a definitive agreement to combine Mylan with Upjohn, Pfizer’s off-patent branded and generic established medicines business, creating a new global pharmaceutical company.
Building a healthier world for everyone – and delivering better outcomes for patients – is Upjohn’s legacy. By marrying its global footprint and the resources of a world-class multinational with the mindset of a startup, the business was set to anticipate change and capture growth opportunities.
Recognized as a world leader in developing medicines for the treatment of central nervous system diseases, disorders, and injuries, the company also manufactures an extensive line of prescription drugs used in the treatment of conditions including heart disease, cancer, and arthritis.
In 1995, Pharmacia & Upjohn was formed through the merger of Pharmacia AB and The Upjohn Company. Pharmacia & Upjohn became a global provider of human health care products, animal health products, diagnostics and specialty products.
Pharmacia & Upjohn was a global pharmaceutical company formed by the merger of Sweden-based Pharmacia AB and the American company Upjohn in 1995. Today the remainder of the company is owned by Pfizer. In 1997, Pharmacia & Upjohn sold several brands to Johnson & Johnson, including Motrin and Cortaid.
Nov 16, 2020 · Pfizer Inc. announced today that it has completed the transaction to spin off its Upjohn Business and combine it with Mylan N.V. to form Viatris Inc..
Nov 16, 2020 · (RTTNews) - Pfizer Inc. (PFE) has completed the transaction to spin off its Upjohn Business and combine it with Mylan N.V. The combined company was renamed Viatris in connection with the closing.
Sep 17, 2020 · Pfizer, Inc. PFE and Mylan MYL announced that the European Commission (EC) has granted final approval for the proposed merger of Pfizer’s Upjohn unit with Mylan to create a new generic ...
